+91 99205 67550
  • HOME
  • Research
  • Role of Oral Metronomic Chemotherapy (OMCT) after CRS+/-HIPEC in Poor Prognosis Peritoneal Mesothelioma

Role of Oral Metronomic Chemotherapy (OMCT) after CRS+/-HIPEC in Poor Prognosis Peritoneal Mesothelioma

at the 11th International Workshop on Peritoneal Malignancy held in PSOGI 2018, Paris, Sept 2018

An Unusual Case of Intraparotid Facial Nerve Schwannoma
Robotic posterior pelvic exenteration for locally advanced rectal cancer: Video vignette
Aberrant Renal Vessels
Cytoreductive Surgery and Peritonectomy Procedures

    APPOINTMENT FORM